| 书目名称 | Histamine in Inflammation |
| 编辑 | Robin L. Thurmond |
| 视频video | http://file.papertrans.cn/428/427224/427224.mp4 |
| 概述 | Provides an overview of the pharmacology of the four histamine receptors and describes how histamine is synthesized and the insights derived from mice where this synthesis is disrupted.Discusses the i |
| 丛书名称 | Advances in Experimental Medicine and Biology |
| 图书封面 |  |
| 描述 | The year 2010 marks the centennial for the identification of histamine and the first glimpse of its many physiological functions. From these initial findings a rich tapestry of research has uncovered roles for histamine in almost every physiological process with new findings emerging every year. These diverse roles of histamine have made for fertile ground for the discovery of novel therapeutics, and these drugs have been so successful that the term “antihistamine” has entered the common lexicon. This volume is an attempt to give a snapshot in time as to the current understanding of the role of histamine in just one important therapeutic area—inflammation. The first three chapters provide some background context for the rest of the book starting out with a historical perspective by Figueroa and Shankley. Bongers et al provide an overview of the pharmacology of the four histamine receptors and the chapter by Hiroshi Ohtsu describes how histamine is synthesized as well as the insights derived from mice where this synthesis is disrupted. The next several chapters discuss disease areas where histamine is known to be involved. Chapter 4 by Thomas Taylor-Clark outlines the role of histam |
| 出版日期 | Book 2010 |
| 关键词 | Histamine; Thurmond; immunity; inflammation; pharmacology; tissue |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-1-4419-8056-4 |
| isbn_ebook | 978-1-4419-8056-4Series ISSN 0065-2598 Series E-ISSN 2214-8019 |
| issn_series | 0065-2598 |
| copyright | The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Busines |
|Archiver|手机版|小黑屋|
派博传思国际
( 京公网安备110108008328)
GMT+8, 2025-8-10 04:40
发表于 2025-3-21 19:09:54
